Search

Start Over Authors Pearson, Steven D., author

1. Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder: final evidence report and meeting summary

Author(s):
Tice, Jeffrey A., author
Whittington, Melanie D., author
Fluetsch, Noemi, author
Zapata, Lorenzo Villa, author
Mendola, Nicolas D., author
Chapman, Rick M., author
Campbell, Jonathan D., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 11, 2020
Subject(s):
Behavior Therapy
Digital Technology
Opiate Substitution Treatment
Opioid-Related Disorders -- therapy
United States

2. Supervised injection facilities and other supervised consumption sites: effectiveness and value : final report

Author(s):
Armbrecht, Eric, author
Guzauskas, Greg, author
Hansen, Ryan, author
Pandey, Rajshree, author
Fazioli, Katherine, author
Chapman, Rick M., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 8, 2021
Subject(s):
Harm Reduction
Needle-Exchange Programs
Opiate Overdose -- prevention & control
Opioid-Related Disorders -- therapy
United States

4. Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value : final report

Author(s):
Atlas, Steven J., author
Touchette, Daniel R., author
Beinfeld, Molly, author
McKenna, Avery, author
Joshi, Mrinmayee, author
Chapman, Rick M., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 15, 2021
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Urinary Bladder Neoplasms -- drug therapy
Genetic Vectors -- therapeutic use
United States

5. Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value

Author(s):
Bradt, Pamela, author
Synnott, Patricia G., author
Chapman, Rick M., author
Beinfeld, Molly, author
Rind, David M., author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020
Subject(s):
Anemia, Sickle Cell -- drug therapy
Antibodies, Monoclonal -- therapeutic use
Glutamine -- therapeutic use
Hemoglobin, Sickle -- antagonists & inhibitors
United States

7. Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report

Author(s):
Tice, Jeffrey A., author
Touchette, Daniel R., author
Nikitin, Dmitriy, author
Campbell, Jon, author
Lien, Pei-Wen, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Agboola, Foluso, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021
Subject(s):
Immunosuppressive Agents
Myasthenia Gravis -- drug therapy
United States

9. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

Author(s):
Tice, Jeffrey A., author
Herron-Smith, Serina, author
Tsiao, Emily, author
Chapman, Rick M., author
Zaim, Remziye, author
Segel, Celia, author
Rind, David, author
Pearson, Steven D., author
Guzauskas, Greg, author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 10, 2019
Subject(s):
Immunotherapy
Peanut Hypersensitivity
United States

10. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

Author(s):
Wasfy, Jason H., author
Walton, Surrey M., author
Beinfeld, Molly, author
Nhan, Emily, author
Sarker, Jyotirmoy, author
Whittington, Melanie D., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 16, 2021
Subject(s):
Cardiac Myosins -- antagonists & inhibitors
Cardiomyopathy, Hypertrophic -- drug therapy
United States